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Apoptotic Pathways: Minireview
The Roads to Ruin
Procaspase aggregation is mediated by the binding
of adaptor molecules to protein interaction domains in
the prodomains of some caspases. Two general types
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of interaction domains have been identified. Procas-
pases-8 and -10 each contain two tandem death effector
domains (DEDs), while procaspases-1, -2, -4, -5, and -9Introduction
contain caspase recruitment domains (CARDs). In eachNearly all physiological cell deaths in animals proceed
case, the procaspases bind to adaptor molecules con-by the process of apoptosis, during which the dying
taining similar domains, and these either directly aggre-cells vanish without a trace, silently cleared without any
gate or interact with other molecules. Although they areaccompanying inflammatory response. Like the last
unrelated, CARDs and DEDs have similar structures,scene of a noir mystery, we can now line up the various
composed of six closely packed, amphipathic antiparal-molecularsuspects in this cell death.Here, we will exam-
lel a helices, a structure that is also found in the deathine recent knockouts and other studies that shed light
domains of Fas and the p75 NGF receptor (Chou et al.,on the pathways that lead to the death of a cell by
1998; Eberstadt et al., 1998).apoptosis.
The result in each case of caspase recruitment is theThe final stage of apoptosis, called execution, occurs
formation of a complex called an ªapoptosomeº thatthrough the activation and function of caspases, a highly
functions to mediate the activation of the caspase (Fig-conserved family of cysteine proteases with specificity
ure 1). Two distinctly different processes have been de-for aspartic acid residues in their substrates. It is the
lineated.cleavage of certain key substrates that orchestrates the
death and packaging of the cell for clearance. The keys
to understanding the molecular basis of apoptosis lie
not only in the identification of these critical caspase
substrates, but also in learning how the caspases that
cleave them come to be activated.
Caspase Activation: The Procaspase
Always Cuts Twice
Caspases are constitutively present in most cells, resid-
ing in the cytosol as a single chain proenzyme. These
are activated to fully functional proteases by a first pro-
teolytic cleavage to divide the chain into large and small
caspase subunits and a second cleavage to remove the
N-terminal domain (prodomain). The subunits assemble
into a tetramer with two active sites (see Figure 1).
Since proteolytic cleavage generates the mature cas-
pases, one way in which these enzymes are activated
is via the action of proteases, including other caspases.
Thus, caspases can function in an activation cascade.
Alternatively, caspases can be activated by other prote-
ases such as granzyme B, which is introduced into cells
by cytotoxic lymphocytes and triggers apoptosis by
cleavage and activation of caspases such as cas-
pase-3. Caspases with short prodomains lackingprotein
interaction motifs (caspases-3, -6, -7) are probably acti-
vated predominantly through the action of other prote-
Figure 1. Two Pathways of Caspase Activation and Apoptosisases. These are sometimes referred to as ªdown-
Two independent apoptosis pathways are presented that convergestream,º ªeffector,º or ªexecutionerº caspases.
on the activation of ªdownstreamº caspases (-3, -6, -7), key sub-While caspase±caspase interactions are almost cer-
strate cleavage, and apoptotic death. The first involves ligation oftainly of central importance, the initial activation of cas-
death receptors by their ligands, resulting in the recruitment of adap-
pases during the apoptotic process must involve some- tor proteins and procaspase molecules. The complex is an ªapopto-
thing more. The key is that the procaspases possess someº in which the aggregated procaspase transactivates. The ac-
activity, albeit less than that of the active caspases; e.g., tive caspase (e.g., caspase-8) then acts to cleave and activate the
procaspase-8 has approximately 1%±2% of the activity downstream caspases. In the second pathway, various forms of
cellular stress trigger mitochondrial release of cytochrome c, whichof the mature caspase-8 enzyme. When procaspase-8
binds to Apaf1, which in turn self-associates and binds procas-molecules are aggregated, this is sufficient to allow
pase-9, resulting in an apoptosome. Transactivation of the com-auto- or transprocessing to produce caspase-8 (Muzio
plexed procaspase-9 to active caspase-9 follows, and the caspase
et al., 1998; Yang et al., 1998). Thus, procaspase aggre- then cleaves and activates downstream caspases. In this model,
gation is an important step leading to caspase activa- there is no cross-talk between the pathways, and ligation of death
tion, which in turn is amplifiedby cleavage and activation receptors does not affect mitochondrial function in a relevant
manner.of downstream caspases.
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Spellbound: Mechanisms of Caspase Aggregation
Upon their ligation, death receptors such as Fas and the
TNF receptor-1 (TNFR1) recruit and oligomerize adaptor
proteins and procaspases. FADD, which contains a
DED, is recruited directly to ligated Fas (and indirectly
to ligated TNFR1), resulting in the recruitment and au-
toactivation of caspase-8. Similarly, the adaptor protein
RAIDD (which has a CARD domain) associates with
TNFR1 and thus may promote aggregation and activa-
tion of procaspase-2. Another adaptor, CARDIAK/RIP2,
binds via CARD±CARD interactions to procaspase-1,
possibly leading to activation.
A related but different way that adaptor proteins
function to activate caspases is seen in the case of
Apaf1, a mammalian homolog of the C. elegans protein
CED-4. In the nematode, it appears that CED-4 pro-
motes developmental cell death by binding to the pro-
caspase CED-3. CED-3 autoactivation then occurs,
probably via aggregation or ATP-driven conformational
changes in CED-4. Similarly, Apaf1 can bind the prodo- Figure 2. Cross-Talk between the Apoptotic Pathways
main of procaspase-9 (via a CARD±CARD interaction) Active caspase-8 (e.g., by ligation of death receptors) cleaves Bid,
while a different region of Apaf1 self-associates, re- producing a C-terminal fragment that then binds to mitochondria
sulting in procaspase aggregation and activation (Srini- and induces release of cytochrome c. The cytochrome c then func-
tions to activate Apaf1 and procaspase-9 processing, which in turnvasula et al., 1998). However, the binding of Apaf1 to
cleaves and processes downstream caspases. It is hypothesizedprocaspase-9 and to itself only occurs in the presence
that inefficient activation of caspase-8 favors this pathway overof cytochrome c. Apaf1 also binds ATP and dATP, and
direct caspase-8-mediated activation of downstream caspases.one or the other are required for efficient cytochrome
Bcl2 and BclX act to prevent cytochrome c release and thus interfere
c±induced caspase-9 activation. Removal of the C-ter- with this pathway.
minal WD repeat domain of Apaf1 eliminates the require-
ment for cytochrome c, leading to the idea that cyto-
chrome c activates Apaf1 function by binding to this
Pathway Cross-Talk: Sorry, Wrong Numberregion (Srinivasula et al., 1998), although this has not
The two basic pathways depicted in Figure 1 make pre-been formally demonstrated. The truncated Apaf1 acti-
dictions about how apoptosis is regulated under differ-vates caspase-9 but apparently does not release it, rais-
ent circumstances. Anti-apoptotic Bcl2 family proteinsing the possibility that conformational changes (perhaps
(e.g., Bcl2, BclXL) bind to mitochondria and inhibit theATP dependent?) may play additional roles in the func-
release of cytochrome c (Kluck et al., 1997; Yang ettion of this apoptosome. This cytochrome c/Apaf1 path-
al., 1997). Therefore, apoptotic signaling via the deathway and the death receptor pathway discussed above
receptor pathway should be resistant to Bcl2. However,both converge on the activation of the downstream cas-
pases (see Figure 1). it seems that Bcl2 and BclX can interfere with Fas- and
While procaspase aggregation and transactivation TNFR-mediated apoptosis in cells in which Fas/FADD/
appear similar in both cases (death receptors versus procaspase-8 recruitment is inefficient (Scaffidi et al.,
Apaf1), the involvement of cytochrome c introduces a 1998). Since Fas and TNFR ligation is associated with
fundamental difference. Only cytochrome c that has release of cytochrome c, it seems likely that cytochrome
been assembled in the mitochondria (i.e., with the c release is important in those cases where Bcl2 inter-
attached heme) functions to activate Apaf1 (Yang et al., feres with death. This raises the possibility of cross-talk
1997), and thus mitochondrial release of cytochrome c between the pathways, such that caspase-8 activates
appears to be critically involved in Apaf1 function. caspase-9 via the mitochondria.
What triggers the release of cytochrome c? In most Recently, a mechanism for such cross-talk was pro-
cases the release of cytochrome c proceeds indepen- vided. Bid, a proapoptotic member of the Bcl2 family,
dently of caspase function (Bossy-Wetzel et al., 1998). is directlycleaved by caspase-8 and the C-terminal frag-
The effect may or may not be associated with a drop in
ment acts on mitochondria to trigger cytochrome c re-
inner mitochondrial membrane potential corresponding
lease (Li et al., 1998; Luo et al., 1998) (Figure 2). Depletion
to the opening of the inner membrane permeability tran-
of Bid from cytosolic extracts disrupts the ability ofsition (PT) pore complex (Green and Reed, 1998). The
caspase-8 to trigger cytochrome c release in vitro. Butproapoptotic Bcl2 family member Bax can directly cause
is this an important mechanismwhereby caspase-8 acti-mitochondria to release cytochrome c (Jurgensmeier et
vates downstream caspases? In Xenopus cytosolical., 1998). Bax shuttles from its cytoplasmic location to
extracts, the ability of small amounts of caspase-8 tothe mitochondria upon induction of apoptosis (Wolter
trigger activation of a caspase-3-likeactivity was depen-et al., 1997). The ability of some Bcl2 family proteins,
dent on the presence of mitochondria (Kuwana et al.,including Bax, to form ion channels has fostered the
1998). This suggests the possibility that caspase-8idea that these proteins open pores or produce breaks
cleaves and activates Bid more efficiently than procas-in the outer mitochondrial membranes, allowing exit of
cytochrome c. pase-3, and in doing so enlists the cytochrome c/Apaf1
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pathway to amplify the caspase-8 function. In the ab- It is important, however, that these caspase knock-
outs did not accurately mimic the Apaf1 knockouts. Thissence of mitochondria, caspase-8 processes procas-
pase-3 with identical kinetics whether or not cytosol is indicates that either Apaf1 can act via a caspase other
than procaspase-9, or that it plays additional roles be-present (Stennicke et al., 1998), and thus other caspases
do not effectively serve as intermediates or amplifiers yond that of execution. The latter is unlikely, however,
since all of the embryonic defects examined corre-of caspase-8 activity. Presumably it is only in those cells
where the mitochondrial amplification loop is important sponded to a lack of apoptosis (Cecconi et al., 1998;
Yoshida et al., 1998). The idea that another caspase maythat antiapoptotic Bcl2 family members can suppress
Fas/TNFR-induced apoptosis (see Figure 2). substitute for procaspase-9 in many cells is appealing,
but currently none of the other caspases appear to beDouble Indemnity: Redundancy in
Apoptotic Pathways activated by Apaf1 (Srinivasula et al., 1998). We might
predict, though, that the prodomain of this replacementHow generally important are these apoptotic pathways?
Keeping inmind the possible problems of compensation caspase will contain a CARD domain. Alternatively, it is
possible that CARD-containing adaptor proteins bridgeand redundancy, knockout studies are beginning to give
us a new respect for the executioner and its compo- Apaf1 to other procaspases. In any case, there are addi-
tional apoptosomes waiting to be uncovered.nents. The effect of targeted disruption of Apaf1 is per-
haps the most dramatic (Cecconi et al., 1998, and Yo- Dial ªMº for Mitochondria: Why Aren't
These Cells Dead?shida et al., 1998 [both in this issue of Cell]). In these
mice, defects are found in essentially all tissues whose One should expect that a knockout of a gene that en-
codes one of the central elements of the executionerdevelopment depends on cell death, including loss of
the interdigital webs, formation of the palate, control of should manifest as cell survival. But a problem emerges
when one considers that triggers of the apoptotic pro-neural cell number, and development of the lens and
retina. Unless additional mechanisms for Apaf1 activa- cess presumably target mitochondria for cytochrome c
release, prior to any involvement of Apaf1, caspase-9,tion exist that have not been identified, these results
suggest that these developmental cell deaths are also or caspase-3 (Figure 1). The result is the disruption of
electron transport, generation of reactive oxygen spe-dependent on mitochondrial release of cytochrome c.
Interestingly, however, some forms of apoptosis were cies, and release of cytochrome c to trigger apoptotic
events. In the absence of Apaf1, caspase-9, or cas-partially or completely intact in these mice. Fas-medi-
ated apoptosis is fully functional in T cells (Yoshida et pase-3, why doesn't the cell die in a caspase-indepen-
dent fashion, due to the disruption of mitochondrialal., 1998) although it may be partially lost in embryonic
fibroblasts (Cecconi et al., 1998), consistent with the function?
First, it is not certain that this isn't the case. Althoughpossible role of Bid/mitochondrial signaling through
Apaf1 in the latter but not the former. Cell death induced the cells of the interdigital webs do not die on schedule
in the Apaf1 knockouts, they do apparently die one orby glucocorticoids, staurosporine, and otheragents was
still partially intact in the absence of Apaf1, and where two days later (Cecconi et al., 1998). Similarly, the resis-
tance to cell death in Apaf12/2 cells was only examinedexamined this appeared to be apoptosis.
It is formally possible that this remaining Apaf1-inde- in a short (24 hr) time frame; subsequent caspase-inde-
pendent death might take longer. However, although al-pendent apoptosis is via death receptor signaling, since
a number of recent studies have shown that cellular ternative Apaf1-independent apoptotic pathways might
be engaged later, it does not appear that cells are com-stress can induce expression of death ligands (e.g., Fas-
ligand) and subsequent apoptosis (Kasibhatla et al., mitted to die by the apoptosis-related mitochondrial
changes that precede the involvement of Apaf1.1998). However, it seems more likely that other undis-
covered Apaf1-like molecules maintain apoptotic re- Experimental evidence supports the idea that cell
death can proceed in the absence of caspases. Whilesponses in these cases.
Caspase knockouts are also extremely interesting, caspase inhibitors block theapoptotic phenotype, death
in cell lines nevertheless proceeds when induced by aalthough here the picture is made much more compli-
cated by the number of different caspases. Little or variety of agents or conditions (Green and Reed, 1998).
Thus, the cells are committed to die even before cas-no effect on apoptosis was observed upon targeted
disruption of caspase-1, -2 (Bergeron et al., 1998), or pases become active. An exception is cell death induced
by ligation of death receptors; in this case the commit--11 (Wang et al., 1998) although knockouts of cas-
pase-1 and -11 did have profound effects on cytokine ment is dependent on caspases, and inhibitors therefore
maintain cell viability.(e.g., IL-1) processing. Of course this does not rule out
roles for these caspases in some forms of apoptosis, The mitochondrial PT that accompanies apoptosis in
many cases is a major candidate mechanism for cas-since others may perform redundant functions.
In contrast, the knockouts of caspase-3 and -9 (Ha- pase-independent death. While PT can occur in the ab-
sence of activecaspases, inmany cases it appears tobekem et al., 1998; Kuida et al., 1998) had profound devel-
opmental effects, especially in the brain. Cells from caspase dependent, even when cytochrome c release is
not (Bossy-Wetzel et al., 1998). Activated Bid was foundthese animals displayed resistance to a number of forms
of apoptosis as well. The relative importance of these to be capable of inducing cytochrome c release from
mitochondria without a loss of mitochondrial transmem-two caspases was elegantly examined in different cells
under different conditions (Hakem et al., 1998), and the brane potential (Luo et al., 1998). Similarly, procaspase-
92/2 cells could be stimulated to release cytochrome cresults illustrate the complexities of these interactions,
in that one or both of these caspases may be essential without a detectable PT (Hakem et al., 1998). The possi-
ble role of a reversible PT is not excluded.in a given setting but not in others.
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Li, H., Zhu, H., Xu, C., and Yuan, J. (1998). Cell 94, 491±501.Thus, while cycling cells (including transformed cells)
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998).cannot survive the caspase-independent mitochondrial
Cell 94, 481±490.changes that contribute toapoptotic pathways, possibly
Mancini, M., Anderson, B., Caldwell, E., Sedghinasab, M., Paty, P.,other cells in the body can. Either mitochondrial function
and Hockenbery, D. (1997). J. Cell Biol. 138, 449±469.remains intact following the cytochrome c release, or
Muzio, M., Stockwell, B.R., Stennicke, H.R., Salvesen, G.S., andnew mitochondria aregenerated denovo in the surviving
Dixit, V.M. (1998). J. Biol. Chem. 273, 2926±2930.cells. Apparent mitochondrial biogenesis in cells trig-
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli,gered to undergo apoptosis has been documented
K.J., Debatin, K.M., Krammer, P.H., and Peter, M.E. (1998). EMBO
(Mancini et al., 1997). J. 17, 1675±1687.
If, however, this recovery does not readily occur in Srinivasula, S., Ahmad, M., Fernandes-Alnemri, T., and Alnemri, E.
dividing cells, then this could explain why defects in the (1998). Mol. Cell 1, 949±957.
apoptotic executioner are not frequently found in can- Stennicke, H.R., Jurgensmeier, J.M., Shin, H., Wolf, B.B., Yang, X.,
cers. In such cells the lack of caspase activation might Zhou, Q., Ellerby, H.M., Ellerby, L.M., Bredesen, D., Green, D.R., et
al. (1998). J. Biol. Chem., in press.not give a significant survival advantage, if the mitochon-
drial events would prove lethal anyway. Thus, tumor Wang, S., Miura, M., Jung, Y.K., Zhu, H., Li, E., and Yuan, J. (1998).
Cell 92, 501±509.cells can be induced to undergo apoptosis and maintain
Wolter, K.G., Hsu, Y.T., Smith, C.L., Nechushtan, A., Xi, X.G., andthe apoptotic machinery intact, because the loss of this
Youle, R.J. (1997). J. Cell Biol. 139, 1281±1292.machinery is not selected. In contrast, tumors do ex-
Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng,press antiapoptotic proteins that act at the level of the
I.-I., Jones, D.P., and Wang, X. (1997). Science 275, 1129±1132.mitochondria (e.g., Bcl2, BclX), since these maintain via-
Yang, X., Chang, H.Y., and Baltimore, D. (1998). Mol. Cell 1, 319±325.bility as well as inhibiting apoptosis. Of course, these
Yoshida, H., Kong, Y.Y., Yoshida, R., Elia, A.J., Hakem, A., Hakem, R.,ideas must await a more thorough examination of onco-
Penninger, J.M., and Mak, T.W. (1998). Cell 94, this issue, 739±750.genesis in Apaf1- or caspase-deficient cells.
Conclusions
During development, uponcellular stress, or in response
to disruption of cell cycle controls, cells engage the
pathways that activate endogenous caspases which or-
chestrate thecells' demiseso that they will beeffectively
and silently cleared. While the nature of these pathways
is now coming into view, we still have little idea of how
developmental signals or stress responses engage
these pathways, or how transcription contributes to
them in many cases. There is more to learn about the
triggers, the pathways, and the central mechanisms,
and just how far down the road to ruin a cell can travel,
and still turn back.
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